AstraZeneca Net Common Equity Issued/Repurchased 2010-2025 | AZN
AstraZeneca net common equity issued/repurchased for the twelve months ending March 31, 2025 was $-0.576B, a 1076.27% decline year-over-year.
- AstraZeneca annual net common equity issued/repurchased for 2024 was $-0.043B, a 230.3% decline from 2023.
- AstraZeneca annual net common equity issued/repurchased for 2023 was $0.033B, a 13.79% increase from 2022.
- AstraZeneca annual net common equity issued/repurchased for 2022 was $0.029B, a 0% decline from 2021.